Skip to content

Clinical trials

Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Country / region: Taiwan Clear all

344 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20032
20041
20053
20065
200712
20085
200911
201013
20118
20127
20138
201420
201514
201613
201718
201835
201928
202021
202115
202225
202321
202422
202522
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed145
Active, not recruiting53
Recruiting46
Terminated44
Unknown status44
Not yet recruiting6
Enrolling by invitation3
Withdrawn2
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie34
National Taiwan University Hospital34
AstraZeneca14
Novartis Pharmaceuticals14
Chang Gung Memorial Hospital12
Amgen10
Astellas Pharma Global Development, Inc.8
Boehringer Ingelheim8
Bayer7
GlaxoSmithKline6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms344
Carcinoma, Non-Small-Cell Lung59
Neoplasm Metastasis35
Breast Neoplasms26
Carcinoma, Hepatocellular25
Colorectal Neoplasms24
Lung Neoplasms24
Neoplasms by Site20
Stomach Neoplasms19
Adenocarcinoma18

Trials

Showing 76 to 100 of 344. Each trial links to its page on Pharma Observatory.

244 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.